BG105807A - Състави с контролирано освобождаване на бетахистин - Google Patents

Състави с контролирано освобождаване на бетахистин Download PDF

Info

Publication number
BG105807A
BG105807A BG105807A BG10580701A BG105807A BG 105807 A BG105807 A BG 105807A BG 105807 A BG105807 A BG 105807A BG 10580701 A BG10580701 A BG 10580701A BG 105807 A BG105807 A BG 105807A
Authority
BG
Bulgaria
Prior art keywords
release tablet
controlled
controlled release
hydrophilic polymer
tablet according
Prior art date
Application number
BG105807A
Other languages
Bulgarian (bg)
English (en)
Inventor
Flavio Fabiani
Enrico Frimonti
Mauro Valenti
Original Assignee
Farmaceutici Formenti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Formenti S.P.A. filed Critical Farmaceutici Formenti S.P.A.
Publication of BG105807A publication Critical patent/BG105807A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG105807A 1999-03-05 2001-08-09 Състави с контролирано освобождаване на бетахистин BG105807A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (1)

Publication Number Publication Date
BG105807A true BG105807A (bg) 2002-03-29

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105807A BG105807A (bg) 1999-03-05 2001-08-09 Състави с контролирано освобождаване на бетахистин

Country Status (37)

Country Link
EP (1) EP1158963B1 (da)
JP (1) JP2002538197A (da)
KR (1) KR20010102498A (da)
CN (1) CN1165295C (da)
AR (1) AR029154A1 (da)
AT (1) ATE231392T1 (da)
AU (1) AU762532B2 (da)
BG (1) BG105807A (da)
BR (1) BR0008739A (da)
CA (1) CA2364226A1 (da)
CO (1) CO5170438A1 (da)
CZ (1) CZ299510B6 (da)
DE (1) DE60001266T2 (da)
DK (1) DK1158963T3 (da)
EE (1) EE200100453A (da)
ES (1) ES2189739T3 (da)
GE (1) GEP20033078B (da)
HK (1) HK1042246B (da)
HR (1) HRP20010650A2 (da)
HU (1) HUP0200243A2 (da)
ID (1) ID30127A (da)
IL (1) IL145263A0 (da)
IT (1) IT1309591B1 (da)
MX (1) MXPA01008893A (da)
NO (1) NO319135B1 (da)
NZ (1) NZ513949A (da)
PE (1) PE20001547A1 (da)
PL (1) PL196290B1 (da)
PT (1) PT1158963E (da)
RU (1) RU2248791C2 (da)
SI (1) SI1158963T1 (da)
SK (1) SK284584B6 (da)
TR (1) TR200102566T2 (da)
UA (1) UA65652C2 (da)
WO (1) WO2000053162A1 (da)
YU (1) YU64001A (da)
ZA (1) ZA200107318B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064807A1 (en) * 2003-01-23 2004-08-05 Amorepacific Corporation Sustained-release preparations and method for producing the same
SI1493435T1 (sl) 2003-07-04 2008-10-31 Formenti Farmaceutici Spa Betahistinski sestavki s kontroliranim sproĺ äśanjem
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
BRPI0506807A (pt) 2004-04-22 2007-05-29 Mor Research Applic Ltd método de gerenciamento de consumo de alimento e composição farmacológica
WO2006009403A1 (en) * 2004-07-22 2006-01-26 Amorepacific Corporation Sustained-release preparations containing topiramate and the producing method thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
AU2009253739B2 (en) 2008-05-27 2014-02-06 Otolanum Ag Methods of treating mammals with eustachian tube dysfunctions
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
EP2491930A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
DK3431078T3 (da) * 2017-07-20 2021-04-19 Intas Pharmaceuticals Ltd Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
PL191399B1 (pl) * 1996-10-28 2006-05-31 Gen Mills Inc Sposób kapsułkowania lub osadzania składnika w osnowie w procesie ciągłym, sposób kapsułkowania i/lub osadzania składników w osnowie opartej na węglowodanach, sposób kapsułkowania i/lub osadzania składników w osnowie oraz kapsułka

Also Published As

Publication number Publication date
AU762532B2 (en) 2003-06-26
PL350232A1 (en) 2002-11-18
NO20014301D0 (no) 2001-09-04
IL145263A0 (en) 2002-06-30
ITMI990454A1 (it) 2000-09-05
RU2248791C2 (ru) 2005-03-27
CO5170438A1 (es) 2002-06-27
CN1342069A (zh) 2002-03-27
CA2364226A1 (en) 2000-09-14
DE60001266D1 (de) 2003-02-27
UA65652C2 (uk) 2004-04-15
HK1042246B (zh) 2005-06-03
KR20010102498A (ko) 2001-11-15
BR0008739A (pt) 2001-12-26
EP1158963A1 (en) 2001-12-05
HUP0200243A2 (en) 2002-06-29
JP2002538197A (ja) 2002-11-12
ATE231392T1 (de) 2003-02-15
SK12492001A3 (sk) 2001-12-03
ZA200107318B (en) 2002-09-04
YU64001A (sh) 2004-05-12
AU3283100A (en) 2000-09-28
EE200100453A (et) 2002-12-16
IT1309591B1 (it) 2002-01-24
HK1042246A1 (en) 2002-08-09
ES2189739T3 (es) 2003-07-16
HRP20010650A2 (en) 2002-10-31
TR200102566T2 (tr) 2002-01-21
CN1165295C (zh) 2004-09-08
AR029154A1 (es) 2003-06-18
CZ299510B6 (cs) 2008-08-20
DK1158963T3 (da) 2003-04-28
DE60001266T2 (de) 2003-08-28
MXPA01008893A (es) 2002-10-23
PT1158963E (pt) 2003-06-30
CZ20013186A3 (cs) 2002-02-13
NO20014301L (no) 2001-09-04
PL196290B1 (pl) 2007-12-31
SK284584B6 (sk) 2005-07-01
NO319135B1 (no) 2005-06-20
ID30127A (id) 2001-11-08
PE20001547A1 (es) 2001-01-29
WO2000053162A1 (en) 2000-09-14
SI1158963T1 (en) 2003-04-30
NZ513949A (en) 2003-10-31
GEP20033078B (en) 2003-10-27
EP1158963B1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
KR100958045B1 (ko) 3-(3-디메틸아미노-1-에틸-2-메틸-프로필)페놀을 함유하고활성 성분의 방출이 지연되는 약제
RU2468788C2 (ru) Фармацевтическая лекарственная форма ингибитора тирозинкиназы для перорального введения
US7976869B2 (en) Fenofibrate tablets
EA014249B1 (ru) Формуляция леветирацетама длительного высвобождения
EP2334284B1 (de) Kompaktiertes cinacalcet
JP2011148813A (ja) フェノフィブレート含有医薬組成物およびこれを調製するための方法
BG105807A (bg) Състави с контролирано освобождаване на бетахистин
US20110151002A1 (en) Sustained release pharmaceutical compositions comprising quetiapine
EP2314286A1 (de) Schmelzgranuliertes Cinacalcet
EP1928441A2 (de) Retardformulierung von 3-(2-dimethylaminomethyl-cyclohexyl)-phenol
AT393625B (de) Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten
US11478432B2 (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
EP1691788A2 (en) Phosphodiesterase v inhibitor formulations
KR101799321B1 (ko) 에페리손 서방성 미립구와 아세클로페낙 복합제제
AU2013201986A1 (en) Capsule Formulation Of Pirfenidone And Pharmaceutically Acceptable Excipients
ITMI20000113A1 (it) Composizioni a rilascio controllato di metamizolo e tramadolo
PL176474B1 (pl) Preparat farmaceutyczny o kontrolowanym uwalnianiu i sposoby wytwarzania preparatu farmaceutycznego o kontrolowanym uwalnianiu